03.14.23 -- How Sanofi Is Using Digital Devices To Improve The Patient Experience

In October 2022, Clinical Leader’s chief editor, Ed Miseta, interviewed Victoria DiBiaso, global head, patient informed development and health value translation, and Terttu Haring, head, clinical innovation office at Sanofi. They discussed the new R&D model, the company’s attempts to make its trials more patient-centric, and how digital technologies and devices are helping to create a better trial experience for patients. In this segment, Haring discusses how the company is incorporating digital devices to improve the patient experience.

Learn how developing a unified solution can improve quality and create efficiency and cost savings for organizations of all sizes conducting clinical trials of all types.

Often hiding in plain sight in the clinical research industry, discover how eSource presents a huge and ready-made opportunity for sponsors to conduct clinical trials more efficiently.

eConsent is imperative for continuing research during the COVID-19 pandemic, but regulations can vary widely across borders. Witness how eConsent is managed in the top countries in clinical research.

Given the decentralization of clinical trials and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”

Master protocol design trials require an endless stream of consent forms, which add time, cost, and risk. A feature-rich electronic consent platform can simplify those processes and improve patient engagement.

Discover how sponsors are turning to innovative solutions that deliver electronic health records to electronic data capture integration to automate documentation and improve site relationships.

Organizations conducting clinical research can streamline collection, processing, and submission of clinical trial data to regulatory authorities to expedite development and approval.

Medable Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.

Don't try to fit cell and gene therapy studies — or any kind of study — into predefined functionality. The Cenduit IRT and Quantum Interactive™ agile design platforms and reporting tools support clients’ most complex requirements.

Discover how elluminate® CTMS Insights keeps trial operations data in one place without the burden of traditional clinical trial management systems.